Department of Infection Control and Immunology, Laboratory of Viral Infection, Ōmura Satoshi Memorial Institute & Graduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.
Department of Aging Intervention, National Center for Geriatrics and Gerontology, Laboratory of Gene Therapy, and Laboratory for Radiation Safety, Aichi, Japan.
J Virol. 2024 Feb 20;98(2):e0126123. doi: 10.1128/jvi.01261-23. Epub 2024 Jan 16.
Human norovirus (HuNoV) causes gastroenteritis, a disease with no effective therapy or vaccine, and does not grow well in culture. Murine norovirus (MNV) easily replicates in cell cultures and small animals and has often been used as a model to elucidate the structural and functional characteristics of HuNoV. An MNV plasmid-based reverse genetics system was developed to produce the modified recombinant virus. In this study, we attempted to construct the recombinant virus by integrating a foreign gene into MNV ORF3, which encodes the minor structural protein VP2. Deletion of VP2 expression abolished infectious particles from MNV cDNA clones, and supplying exogenous VP2 to the cells rescued the infectivity of cDNA clones without VP2 expression. In addition, the coding sequence of C-terminal ORF3 was essential for cDNA clones compensated with VP2 to produce infectious particles. Furthermore, the recombinant virus with exogenous reporter genes in place of the dispensable region of ORF3 was propagated when VP2 was constitutively supplied. Our findings indicate that foreign genes can be transduced into the norovirus ORF3 region when VP2 is supplied and that successive propagation of modified recombinant norovirus could lead to the development of norovirus-based vaccines or therapeutics.IMPORTANCEIn this study, we revealed that some of the coding regions of ORF3 could be replaced by a foreign gene and infectious virus could be produced when VP2 was supplied. Propagation of this virus depended on VP2 being supplied , indicating that this virus could infect only once. Our findings help to elucidate the functions of VP2 in the virus lifecycle and to develop other caliciviral vectors for recombinant attenuated live enteric virus vaccines or therapeutics tools.
人诺如病毒(HuNoV)会引起肠胃炎,这种疾病目前尚无有效疗法或疫苗,且不易在细胞培养中生长。鼠诺如病毒(MNV)在细胞培养物和小动物中容易复制,常被用作阐明 HuNoV 结构和功能特征的模型。建立了基于 MNV 质粒的反向遗传学系统来产生修饰的重组病毒。在这项研究中,我们试图通过将外源基因整合到编码次要结构蛋白 VP2 的 MNV ORF3 中构建重组病毒。删除 VP2 的表达会使 MNV cDNA 克隆产生的感染性颗粒丧失,而向细胞提供外源 VP2 则可挽救无 VP2 表达的 cDNA 克隆的感染性。此外,ORF3 的 C 末端编码序列对于用 VP2 补偿的 cDNA 克隆产生感染性颗粒是必需的。此外,当持续提供 VP2 时,用外源报告基因替代 ORF3 的非必需区的重组病毒可增殖。我们的研究结果表明,当提供 VP2 时,外源基因可转导到诺如病毒 ORF3 区,并且经过修饰的重组诺如病毒的连续增殖可能导致诺如病毒疫苗或治疗剂的开发。
在这项研究中,我们揭示了 ORF3 的一些编码区可以被外源基因取代,并且当提供 VP2 时可以产生感染性病毒。该病毒的繁殖依赖于 VP2 的供应,表明该病毒只能感染一次。我们的研究结果有助于阐明 VP2 在病毒生命周期中的功能,并开发其他杯状病毒载体,用于重组减毒活肠道病毒疫苗或治疗工具。